Earnings Release • Oct 30, 2024
Earnings Release
Open in ViewerOpens in native device viewer
Decision to invest additional USD 25 million in second production line in the new US plant
| Q3 | Q3 | YTD | YTD | LTM | FY | |
|---|---|---|---|---|---|---|
| (mEUR) | 2024 | 2023 | 2024 | 2023 | 2024 | 2023 |
| Revenue | 292.8 | 283.5 | 873.1 | 844.9 | 1 160.3 | 1 132.2 |
| Revenue growth | 3.3 % | 4.1 % | 3.3 % | 11.7 % | 4.3 % | 10.6 % |
| EBITDA 1) 4) | 45.4 | 48.3 | 135.3 | 130.8 | 175.3 | 170.8 |
| Adjusted EBITDA 1) | 45.4 | 48.3 | 135.3 | 130.8 | 175.2 | 170.9 |
| Adjusted EBITDA margin 1) | 15.5 % | 17.0 % | 15.5 % | 15.5 % | 15.1 % | 15.1 % |
| Leverage ratio 1) | 2.1 | 2.1 | 1.9 | |||
| ROCE 1) | 16.8 % | 15.6 % | 16.7 % | |||
| Adjusted profit attributable to Elopak shareholders | 15.2 | 19.5 | 52.7 | 54.8 | 66.2 | 68.3 |
| Adjusted basic and diluted earnings per share (in EUR) 2) | 0.06 | 0.07 | 0.20 | 0.20 | 0.25 | 0.25 |
| People performance | ||||||
| TRI 3) | 5.4 | 3.3 | 3.9 |
1) Definition of Alternative Performance Measures (APM), including specification for adjustments, at the end of this report 2) Adjusted basic and diluted EPS LTM is calculated based on quarterly EPS values
3) Total Recordable Injury (TRI) frequency rate, last twelve-month average
4) As of Q3 2024, we have redefined our definition of EBITDA to include earnings from joint ventures. See the APM-note for details

The third quarter of 2024 was an eventful quarter. In the beginning of September, we had the pleasure of hosting our first Capital markets day where we presented our strategy "Repackaging tomorrow". With the new strategy we presented our new long-term ambition of becoming a EUR 2 billion company by 2030. The event attracted wide interest from investors, analysts, and other stakeholders with over 200 people taking part in Oslo and via webcast. Later in September, we announced our first step towards reaching our long-term ambition, the investment of an additional US 25 million in a second production line in the new production plant under construction in the US announced in June 2023. The investment in the second line is a response to the continued strong demand we see for our high-quality, innovative, and sustainable solutions in Americas. To date around USD 40 million of the total investment of USD 95 million for the land, building and two first production lines has been paid out.
For us at Elopak, safety is a commitment and license to operate. In the quarter, the TRI (Total Recordable Injuries) for the Group was 5.4, up from 3.3 in the same quarter last year. The number of recordable incidents is too high. We work continuously on strengthening our safety culture to reach our long-term target of 3.2 and have in the shortterm also implemented additional safety interventions as countermeasures.
In EMEA, we continue to see positive momentum in our central and northern European markets with our new tethered caps solutions contributing to another quarter gaining new business and increasing our market share. In the southern European markets and MENA, the high inflationary pressure is increasingly affecting consumption with consumers downtrading to lower cost products.
In Americas, we have largely been able to mitigate the effects of the supply chain incident at one of our board suppliers related to a planned maintenance in the end of June. The incident led to shortage of board, resulting in a backlog in our production. This has had an adverse effect on the volumes as the plant in Canada is running at full capacity without possibility to recover the production backlog. Despite the incident we have delivered stable financial results through increased sale of filling machines and closures, which reached all-time high in terms of volumes and revenues.
Overall, the financial performance over the first three quarters of the year has been strong, with organic revenue growth of 3.4% compared to 2023, despite the volatile macro-economic and geo-political conditions. For the full year, we expect to deliver revenues in line with our current run rate, with full-year EBITDA-margin above 15%.
"I am pleased to see that we continue to deliver profitable growth through new business and increased market share across our core markets, as well as strong filling machine sales. Recording all-time high quarterly revenue in a quarter with challenging market conditions where consumer spend is strained in many markets and capacity contains and supply chain challenges in the Americas demonstrates the resilience of our revenue run rate"
Thomas Körmendi, Chief Executive Officer

In 2023, Elopak had delivered on all its 3-5 year financial targets and strategic priorities set in the IPO in 2021. In the same period, Elopak embarked on the journey from being the world's largest fresh liquid carton packaging company to becoming a leading fiber-based packaging company for liquid and wet products. In September, Elopak presented its new strategic priorities and mid-term targets in the strategy "Repackaging tomorrow". People demand more responsible choices: consumers, customers, and society alike. Elopak's strategy aims to capitalize on the global shift away from plastic. In the strategy, Elopak has defined three strategic priorities to outgrow the market and strengthen its profitability through its position as sustainability frontrunner, offering market leading technology in fiber-based packaging, with a long-term ambition of becoming a EUR 2 billion company by 2030.
For the coming 3-5-year period, Elopak aims to deliver:
These three priorities are further described on the following page.
Elopak will accelerate growth in its margin accretive markets in North America, MENA, and India. In the US, a new state-of-the-art production plant is under construction. The plant has the potential to double revenues in the Americas and is the first step towards realizing Elopak's longterm ambition to become a EUR 2 billion company. In MENA, Elopak aims to leverage its #1 position in the fresh market to become the leading full system supplier in multiple segments, like extended shelf life and aseptic. In India, the world's largest dairy market, Elopak aims to broaden its offering by expanding local production to offer Pure-Pak® solutions.
Elopak will strengthen its #1 position in European markets as customers continue their shift towards more sustainable fiber-based packaging solutions. By leveraging its innovation capabilities and sustainability frontrunner position, Elopak will deliver above-market growth in core markets.
Plastic dominates grocery packaging with around 60% share, representing a new and large addressable market. Elopak will build on its sustainability frontrunner - and first mover position to increase sales of Elopak's current and next generation D-PAK™ carton solutions within the personal and home care segment. In the liquid food segment, Elopak will explore new applications that require other formats than what is in our portfolio today. The growth in adjacent food segment and new verticals will be enabled through partnerships and acquisitions.
Related to our strategy, updated people and planet targets have been developed:
In addition to the mid-term financial targets, Elopak introduced new people and planet targets, which reaffirms the company's strong safety and sustainability commitments. By 2030, 100% of Elopak's cartons will be designed for recycling. In parallel, Elopak will work to reduce its Scope 3 emissions by 25 per cent compared to 2020 levels, while doubling revenues, on its way to becoming a net zero company by 2050.
Elopak makes no compromises on safety. The ultimate ambition is zero work related injuries. By 2030, Elopak targets a Total Recordable Incident Rate (TRI) below 3.2, a reduction of around 40% compared to today (5.4). People's safety is not
only a core value, but a licence to operate and a central part in our sustainable value creation.
For more information on Elopak's strategy, "Repackaging tomorrow", see our Investor Relations website: www.elopak.com/ repackaging-tomorrow
In September, Suzano, the largest pulp manufacturer in the world and one of the largest paper producers in Latin America completed the acquisition of Pactiv Evergreen's liquid packaging board (LPB) mills Pine Bluff and Waynesville in the US. The acquisition is the first move by Suzano into the US liquid packaging market, which Suzano has indicated that they want to scale up to meet the global demand for paper packaging. Pactiv Evergreen, now Suzano, is one of Elopak's suppliers of LPB in the Americas. Pactiv Evergreen retains its converting business and will hence continue to be a competitor of Elopak in Americas.

In the third quarter of 2024, Elopak's consolidated revenues were EUR 292.8 million, an increase of 3.3% compared to the same period last year. Adjusting for currency translation effects, the increase was 3.6%. The increase is mainly related to increased filling machine sales. EBITDA was EUR 45.4 million (EUR 48.3 million) with an EBITDA margin of 15.5% (17.0%). The third quarter in the previous year was at an all-time high and included a favorable one-off of EUR 2 million. Increased salary inflation and FTE increases have also impacted the Group's margins.
On a year to date basis, Group revenues were EUR 873.1 million, an increase of 3.3% compared to the same period last year. The increase is in large coming from increased filling machine sales. Closure volumes have been ramping up throughout the year, stemming from increased market shares in both Europe and the Americas. On a year to date basis, EBITDA for the Group increased by EUR 4.4 million to EUR 135.3 million. The increase was predominantly the result of the volume growth in closures, as well as positive developments with the Group's joint ventures, offset somewhat by salary inflation.

The revenues for the quarter were EUR 217.7 million, down 1.6% compared to the same quarter last year. Pure-Pak® volumes increased in central and northern Europe year on year, through gaining of new business and increasing market share. We are seeing consumption decline in some segments in southern Europe and MENA, as high inflationary pressure is increasingly affecting consumers' cost of living. The fresh dairy segment has declined in both southern Europe and MENA, as consumers are shifting to cheaper end-products. As orange prices are surging due to both drought in Brazil and agricultural diseases in Brazil and Florida, we see muted demand for juice in southern Europe. Volumes in MENA are negatively impacted in the quarter by timing effects but are expected to normalize in the next quarter. Roll Fed volumes have slightly increased in EMEA, with our increasing volumes in India more than offsetting reduced volumes in
Europe. Closure sales have been strong year on year, as Elopak's new tethered caps solutions are contributing to increased market shares in the central and northern part of Europe.
The EBITDA was EUR 36.0 million (EUR 40.2 million) in the quarter with an EBITDA margin of 16.5% (18.1%). The decrease in margin is partly related to the favorable one-off of EUR 2 million reported in the previous quarter, responsible for almost half of the reduction. The strong Roll Fed volume in India contributed positively to the EBITDA, although this was offset by volume declines in Roll Fed in Europe. Fixed costs increased in the period in line with inflation, as well as R&D and FTE increases related to strategic initiatives.
In EMEA, revenues year to date were 667.8 million, an increase of 2.6%, with an EBITDA margin of

In the Americas, revenues were EUR 79.3 million, an increase of 10.0% compared to the same quarter last year. The growth was mainly related to increased filling machine sales. Pure-Pak® volumes increased year on year through new customer contracts, as well as volume growth with existing customers. From a segment perspective, the growth was mainly attributable to fresh dairy, while juice and plant-based remained stable. During the quarter, the region has navigated through the after-effects of the supply chain incident in June, which in isolation has had adverse effects on both volumes and mix. The plant is back to running at full capacity. Closure sales have also been strong in the quarter, reaching all-time high in terms of volumes and revenues.
The EBITDA increased to EUR 17.6 million (EUR 16.4 million) in the quarter, with a margin of 22.2% (22.8%). The increase is in large driven by increased sales of filling machines. Pure-Pak® was marginally negative, due to the increased volumes being more than offset by unfavorable mix effects, in part due to the supply chain challenge. This was mostly outweighed by the positive contribution from strong closure sales. Fixed costs increased in the quarter, mostly due to wage inflation and IT projects. The strong performance in joint ventures continues, and our share of their net income increased by EUR 0.2 million in the quarter to EUR 2.1 million.
The revenues year to date were EUR 226.2 million, an increase of 7.6%, with an EBITDA margin of 23.0% (22.1%).
72

In the third quarter of 2024, operating profit was EUR 26.6 million (EUR 30.4 million). Profit before tax from continuing operations was EUR 17.2 million (EUR 26.7 million).
Net financial items increased by EUR 6.0 million to EUR 11.5 million for the quarter. The increase was mainly driven by negative fair value changes to our financial instruments of EUR 9.9 million. Lower EUR interest rates resulted in a negative fair value change of EUR 4.1 million on the interest rate swaps, while the cross-currency swaps used to hedge the NOK green bonds had a negative fair value change of EUR 5.8 million. This negative change in the fair value of the crosscurrency swaps was more than offset by foreign exchange gain on the NOK bonds. In total the foreign exchange gain in the quarter was EUR 4.2
million (EUR -0.5 million). See note 4 for more details on net financial items.
The tax expense for the quarter was EUR 1.6 million (EUR 7.3 million). This is a result of low er profit before taxes and currency translation effects of EUR 2.5 million in the period due to weaker NOK against EUR. See note 5 for a recon ciliation of the tax expense in the quarter.
Year to date operating profit was EUR 80.2 mil lion, a decrease of EUR 0.3 million. Profit before tax from continuing operations was EUR 68.5 million in 2024, a decrease of EUR 1.0 million. Profit from continuing operations decreased by EUR 1.9 million to EUR 54.0 million.

Year to date 2024, cash flow from operations was EUR 94.1 million. The strong EBITDA is somewhat offset by taxes paid, as well as negative effects from working capital. The negative cash effects from working capital were especially apparent in the third quarter, mainly affected by the timing and volume of payables related to packaging material, as well as seasonal build-up of inventories ahead of plant maintenance in the fourth quarter. Additionally, the filling machine inventories remain at higher than desired levels. As stated in the Q2 report, the Group has initiated mitigating activities to improve working capital levels, although not expected to have a significant effect prior to 2025.
Net cash flow from investing activities was EUR -62.9 million. This reflects our investments in the new US plant of EUR 35.5 million for the period, as well as a normal level of leased filling machines and manufacturing plant projects in Europe. This is offset by EUR 4.0 million in dividends received from our joint venture business, as well as EUR 2.0 million installment from the sale of our Russian subsidiary. The installment was based on an agreement from 2022 to fully divest from all Russian operations.
Net cash flow from financing activities was EUR -23.1 million. The development is largely explained by the dividend paid to our shareholders of EUR 34.4 million in the second quarter, as well as lease and interest payments. Interest-bearing liabilities increased as a result by EUR 41 million.

Consolidated financial statements
| Quarter ended September 30 Year to date ended September 30 | Full year | ||||
|---|---|---|---|---|---|
| (EUR 1,000) NOTE |
2024 | 2023 | 2024 | 2023 | 2023* |
| Revenues 2 |
292 804 | 283 460 | 873 110 | 844 877 | 1 132 043 |
| Other operating income | 24 | 33 | 25 | 35 | 145 |
| Total income 3 |
292 827 | 283 493 | 873 136 | 844 912 | 1 132 187 |
| Cost of materials | (184 835) | (175 449) | (544 932) | (532 580) | (719 796) |
| Payroll expenses | (49 820) | (46 517) | (151 093) | (140 995) | (189 623) |
| Depreciation and amortization expenses | (16 567) | (15 658) | (47 369) | (45 652) | (60 147) |
| Impairment of non-current assets | (97) | (400) | (672) | (567) | (1 186) |
| Other operating expenses | (14 922) | (15 094) | (48 823) | (44 592) | (58 658) |
| Total operating expenses | (266 242) | (253 118) | (792 889) | (764 386) (1 029 409) | |
| Operating profit 3 |
26 586 | 30 375 | 80 247 | 80 526 | 102 778 |
| Financial income | 5 614 | 2 686 | 11 644 | 7 607 | 7 807 |
| Financial expenses | (11 498) | (7 713) | (26 213) | (21 669) | (26 545) |
| Foreign exchange gain/(loss) | 4 229 | ( 494) | 1 836 | ( 474) | (498) |
| Fair value changes on financial instruments | (9 863) | ( 22) | (5 959) | ( 523) | (5 518) |
| Net financial items 4 |
(11 517) | (5 543) | (18 691) | (15 059) | (24 754) |
| Share of net income from joint ventures | 2 127 | 1 894 | 6 981 | 4 102 | 6 855 |
| Profit before tax from continuing operations | 17 196 | 26 726 | 68 537 | 69 569 | 84 880 |
| Income tax 5 |
(1 639) | (7 348) | (14 493) | (13 671) | (15 513) |
| Profit from continuing operations | 15 556 | 19 378 | 54 043 | 55 898 | 69 366 |
| Discontinued operations Russia | - | - | (131) | (1 339) | (1 339) |
| Profit/(loss) from discontinued operations | - | - | (131) | (1 339) | (1 339) |
| Profit/(loss) | 15 556 | 19 378 | 53 912 | 54 559 | 68 027 |
| Profit attributable to: | |||||
| Elopak shareholders | 15 169 | 19 479 | 52 540 | 53 475 | 67 061 |
| Non-controlling interest | 387 | (101) | 1 372 | 1 084 | 966 |
| Basic and diluted earnings per share from continuing operations (in EUR) | 0.06 | 0.07 | 0.20 | 0.20 | 0.25 |
| Basic and diluted earnings per share from discontinued operations (in EUR) | 0.00 | 0.00 | 0.00 | 0.00 | (0.00) |
| Basic and diluted earnings per share attributable to Elopak shareholders (in EUR) | 0.06 | 0.07 | 0.20 | 0.20 | 0.25 |
| Year to date ended September 30 |
Full year | |||
|---|---|---|---|---|
| 2024 | 2023 | 2024 | 2023 | 2023* |
| 27 | (29) | 38 | 54 | (81) |
| (11 241) | 2 802 | (7 543) | 5 278 | 375 |
| (477) | 133 | (189) | 36 | (383) |
| 1 466 | 1 844 | 2 420 | (1 297) | (1 517) |
| (10 226) | 4 749 | (5 274) | 4 071 (1 606) | |
| 66 421 | ||||
| 5 421 | 24 095 | 47 456 | 57 510 | 65 838 |
| (90) | 32 | 1 182 | 1 120 | 583 |
| 5 331 | Quarter ended September 30 |
24 127 48 638 58 630 |
*Audited
| (EUR 1,000) | September 30, September 30, | December 31, | |
|---|---|---|---|
| ASSETS NOTE |
2024 | 2023 | 2023* |
| Development cost and other intangible assets | 54 201 | 62 860 | 62 300 |
| Deferred tax assets | 19 883 | 22 064 | 22 883 |
| Goodwill | 105 947 | 105 600 | 106 061 |
| Property, plant and equipment | 228 298 | 194 984 | 202 934 |
| Right-of-use assets | 91 841 | 79 716 | 86 370 |
| Investment in joint ventures | 39 401 | 41 065 | 37 709 |
| Other non-current assets | 14 105 | 17 415 | 14 892 |
| Total non-current assets | 553 677 | 523 705 | 533 149 |
| Inventory | 191 077 | 206 324 | 192 189 |
| Trade receivables | 114 760 | 107 923 | 110 243 |
| Other current assets | 128 872 | 118 402 | 113 720 |
| Cash and cash equivalents | 21 325 | 28 676 | 13 308 |
| Total current assets | 456 034 | 461 324 | 429 460 |
| Total assets | 1 009 711 | 985 029 | 962 610 |
*Audited
| (EUR 1,000) | September 30, | September 30, | December 31, | |
|---|---|---|---|---|
| EQUITY AND LIABILITIES | NOTE | 2024 | 2023 | 2023* |
| Attributable to Elopak shareholders | 319 432 | 297 961 | 306 253 | |
| Non-controlling interest | 10 225 | 9 580 | 9 043 | |
| Total equity | 329 657 | 307 542 | 315 296 | |
| Pension liabilities | 2 314 | 2 450 | 2 502 | |
| Deferred tax liabilities | 13 495 | 16 870 | 14 041 | |
| Non-current interest bearing liabilities | 6 | 232 708 | 259 333 | 224 433 |
| Non-current lease liabilities | 83 088 | 77 756 | 78 424 | |
| Other non-current liabilities | 8 971 | 4 972 | 5 033 | |
| Total non-current liabilities | 340 576 | 361 381 | 324 434 | |
| Current interest bearing liabilities | 6 | 52 908 | 20 794 | 19 333 |
| Trade payables | 116 378 | 112 634 | 127 847 | |
| Taxes payable | 921 | 5 915 | 6 997 | |
| Public duties payable | 23 441 | 27 953 | 25 066 | |
| Current lease liabilities | 22 973 | 17 920 | 23 096 | |
| Other current liabilities | 122 858 | 130 891 | 120 540 | |
| Total current liabilities | 339 478 | 316 107 | 322 880 | |
| Total liabilities | 680 054 | 677 488 | 647 314 | |
| Total equity and liabilities | 1 009 711 | 985 029 | 962 610 |
*Audited
| Year to date ended September 30 | |||||
|---|---|---|---|---|---|
| (EUR 1,000) | NOTE | 2024 | 2023 | 2023* | |
| Profit before tax from: | |||||
| Continuing operations | 68 537 | 69 569 | 84 880 | ||
| Discontinued operations | (131) | (1 339) | (1 339) | ||
| Profit before tax (including discontinued operations) | 68 405 | 68 230 | 83 540 | ||
| Interest on borrowings | 10 996 | 8 743 | 11 303 | ||
| Lease liability interest | 5 888 | 4 956 | 6 566 | ||
| Profit before tax and interest paid | 85 290 | 81 929 | 101 410 | ||
| Depreciation, amortization and impairment losses | 48 040 | 46 219 | 61 332 | ||
| Net (gains), losses from disposals, impairments and change | 3 602 | 2 494 | 8 630 | ||
| in fair value of financial assets and liabilities 1) | |||||
| Net unrealized currency (gain)/loss | (2 344) | (978) | (174) | ||
| Income from joint ventures | (6 981) | (4 102) | (6 855) | ||
| Net (gain)/loss on sale of non-current assets | 10 | (38) | (13) | ||
| Income taxes paid | (22 114) | (10 396) | (14 270) | ||
| Change in trade receivables | (5 447) | (5 418) | (9 275) | ||
| Change in other current assets | (3 207) | (13 375) | (5 265) | ||
| Change in inventories | 922 | (18 130) | (6 982) | ||
| Change in trade payables | (10 109) | (11 100) | 3 897 | ||
| Change in other current liabilities 1) | 6 560 | 40 791 | 24 982 | ||
| Change in net pension liabilities | (147) | (166) | (228) | ||
| Net cashflow from operating activities | 94 076 | 107 729 | 157 189 | ||
| Purchase of non-current assets | (68 099) | (19 704) | (40 774) | ||
| Proceeds from sale of non-current assets | - | - | 122 | ||
| Proceeds from sale of financial assets and businesses | 2 028 | 4 883 | 4 883 | ||
| Dividend from joint ventures | 4 018 | 923 | 2 018 | ||
| Change in other non-current assets | (849) | 560 | 1 772 | ||
| Net cash flow from investing activities | (62 901) | (13 337) | (31 978) |
| Year to date ended September 30 | Full year | ||||
|---|---|---|---|---|---|
| (EUR 1,000) | NOTE | 2024 | 2023 | 2023* | |
| Proceeds from borrowings | 267 828 | 864 295 | 1 087 304 | ||
| Repayment of borrowings | (226 879) | (914 846) | (1 174 598) | ||
| Interest on borrowings | (10 996) | (8 743) | (11 303) | ||
| Lease payments | (16 991) | (12 312) | (18 359) | ||
| Dividend paid to equity holders of Elopak ASA | (34 430) | (19 634) | (19 634) | ||
| Purchase of treasury shares | (1 589) | (252) | (885) | ||
| Net cash flow from financing activities | (23 058) | (91 492) | (137 475) | ||
| Effects of exchange rate changes on cash and cash equivalents | (100) | (108) | (310) | ||
| Net change in cash and cash equivalents | 8 017 | 2 793 | (12 574) | ||
| Cash and cash equivalents at the beginning of the year | 13 308 | 25 883 | 25 883 | ||
| Cash and cash equivalents at the end of the period | 21 325 | 28 676 | 13 308 | ||
| *Audited |
1) Reclassification of change in fair value of financial assets and liabilities
| (EUR 1,000) | Note | Share capital |
Other paid in capital |
Currency trans lation reserve |
Cash flow hedge reserve |
Retained earnings |
Non-controlling interest |
Total equity |
|---|---|---|---|---|---|---|---|---|
| Total equity 01.01 | 50 104 | 70 548 | (27 103) | (4 275) | 216 977 | 9 043 | 315 295 | |
| Profit for the period | - | - | - | - | 52 540 | 1 372 | 53 912 | |
| Other comprehensive income for the period net of tax | - | - | (7 543) | 2 420 | 38 | (189) | (5 274) | |
| Total comprehensive income for the period | - | - | (7 543) | 2 420 | 52 579 | 1 182 | 48 638 | |
| Dividend paid | - | - | - | - | (34 430) | - | (34 430) | |
| Share based payments | - | 1 443 | - | - | (224) | - | 1 219 | |
| Treasury shares | (38) | (1 026) | - | - | - | - | (1 064) | |
| Total capital transactions in the period | (38) | 417 | - | - | (34 654) | - | (34 275) | |
| Total equity 30.09 | 7 | 50 066 | 70 964 | (34 646) | (1 854) | 234 902 | 10 225 | 329 657 |
| (EUR 1,000) | Note | Share capital |
Other paid in capital |
Currency trans lation reserve |
Cash flow hedge reserve |
Retained earnings |
Non-controlling interest |
Total equity |
|---|---|---|---|---|---|---|---|---|
| Total equity 01.01 | 50 155 | 69 987 | (27 477) | (2 758) | 169 584 | 8 477 | 267 967 | |
| Profit for the period | - | - | - | - | 53 475 | 1 084 | 54 559 | |
| Other comprehensive income for the period net of tax | - | - | 5 278 | (1 297) | 54 | 36 | 4 071 | |
| Total comprehensive income for the period | 5 278 | (1 297) | 53 529 | 1 120 | 58 630 | |||
| - | ||||||||
| Dividend paid | - | - | - | - | (19 634) | (16) | (19 650) | |
| Share based payments | - | 1 060 | - | - | - | - | 1 060 | |
| Treasury shares | (44) | (422) | - | - | - | - | (466) | |
| Total capital transactions in the period | (44) | 638 | - | - | (19 634) | (16) | (19 056) | |
| Total equity 30.09 | 50 110 | 70 625 | (22 199) | (4 055) | 203 479 | 9 580 | 307 541 |
Note 1 Company information and basis of preparation
The Elopak Group consists of Elopak ASA and its subsidiaries. Elopak ASA is a public limited company incorporated in Norway and listed on Oslo Stock Exchange. The Elopak Group is a leading global supplier of carton packaging and filling equipment, which supplies both the fresh and aseptic segments. The consolidated financial information has not been subject to audit or review.
All numbers are presented in EUR 1,000 unless otherwise is clearly stated. The subtotals in some of the tables may not equal the sum of the amounts shown due to rounding. Certain amounts in the comparable periods in the note disclosures have been reclassified to conform to current period presentation.
The Board of Directors approved the condensed consolidated interim financial statements for the period ended September 30, 2024 on October 29, 2024.
The condensed consolidated interim financial statements have been prepared in accordance with International Financial Reporting Standard (IFRS), IAS 34 "Interim Financial Reporting". The condensed interim financial statements do not include all information and disclosures required in the annual financial statement and should be read in conjunction with the Group's Annual Report for 2023, which has been prepared according to IFRS as adopted by EU. The accounting policies applied in the preparation of the consolidated interim financial statements are consistent with those applied in the preparation of the annual IFRS financial statements for the year ended December 31, 2023.
The preparation of interim financial statements requires the Group to make certain estimates and assumptions that affect the application of accounting policies and reported amounts of assets, liabilities, income, and expenses. Estimates and judgements are continually evaluated by the company based on historical experience and other factors, including expectations of future events that are deemed to be reasonable under the circumstances. Actual results may differ from these estimates. The most significant judgements used in preparing these interim financial statements and the key areas of estimation uncertainty are the same as those applied in the consolidated annual report for 2023.
The annual report for 2023 provides a description of the uncertainties and risks for the business.
The Group's revenues consist of revenue from contracts with customers (99%) and rental income from lease of filling equipment (1%). Revenues are primarily derived from the sale of cartons and closures, sales and rental income related to filling equipment and service. The tables include continuing operations only.
As described in the accounting policy for revenues in the annual report for 2023, and in compliance with IFRS 15, the Group recognizes revenue over time for goods without alternative use where the Group has a legally enforceable right to payment. This gives a positive effect on revenue and EBITDA in times where the inventory level of such goods is increasing and negative effect in times where the inventory level of such goods is decreasing. The impact on revenue for the quarter is EUR 0.9 million for 2024 and EUR 4.3 million for 2023.Year to date impact on revenue is EUR (0.1) million and EUR 15.9 million for 2024 and 2023 respectively.
| Revenues specified by geographical area | Quarter ended September 30 | Year to date ended September 30 | |||
|---|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 | |
| USA | 60 647 | 51 781 | 172 054 | 155 705 | |
| Germany | 44 068 | 37 918 | 124 114 | 119 261 | |
| Canada | 20 554 | 21 863 | 59 994 | 58 902 | |
| Netherlands | 15 402 | 14 372 | 46 722 | 44 687 | |
| Norway | 4 784 | 6 988 | 15 579 | 21 317 | |
| Other | 147 349 | 150 538 | 454 647 | 445 005 | |
| Total revenue | 292 804 | 283 460 | 873 110 | 844 877 |
The revenues are specified by location (country) of the customer.
| (EUR 1,000) | Other and | |||
|---|---|---|---|---|
| Quarter ended September 30, 2024 | EMEA | Americas | eliminations | Total |
| Cartons and closures | 184 507 | 69 560 | (584) | 253 484 |
| Equipment | 16 326 | 8 528 | - | 24 854 |
| Service | 14 248 | - | (355) | 13 893 |
| Other | 2 622 | 1 233 | (3 283) | 572 |
| Total revenue | 217 703 | 79 322 | (4 221) | 292 804 |
| Quarter ended September 30, 2023 | EMEA | Americas | Other and eliminations |
Total |
| Cartons and closures | 189 600 | 67 765 | (1 371) | 255 993 |
| Equipment | 16 287 | 3 967 | (5 918) | 14 336 |
| Service | 13 519 | - | (365) | 13 154 |
| Other | 1 814 | 350 | (2 187) | (24) |
| Total revenue | 221 221 | 72 081 | (9 842) | 283 460 |
| Year to date ended September 30, 2024 | EMEA | Americas | Other and eliminations |
Total |
| Cartons and closures | 568 766 | 209 329 | (2 142) | 775 953 |
| Equipment | 46 113 | 14 525 | (8 425) | 52 213 |
| Service | 44 766 | - | (1 102) | 43 664 |
| Other | 8 094 | 2 340 | (9 153) | 1 280 |
| Total revenue | 667 739 | 226 194 | (20 822) | 873 110 |
| Year to date ended September 30, 2023 | EMEA | Americas | Other and eliminations |
Total |
| Cartons and closures | 577 863 | 205 268 | (3 138) | 779 993 |
| Equipment | 27 048 | 3 993 | (5 947) | 25 094 |
| Service | 38 519 | - | (808) | 37 711 |
| Other | 7 556 | 967 | (6 442) | 2 080 |
| Total revenue | 650 986 | 210 228 | (16 335) | 844 877 |
Information reported to the Group's chief operating decision makers, the Group Leadership Team, for the purpose of resource allocation and assessment of segment performance is focused on two key geographical regions – EMEA and Americas. Key figures representing the financial performance of these segments are presented in the following note. GLS Elopak is included in EMEA. The tables include continuing operations only.
| Quarter ended September 30, 2024 | EMEA | Americas | Other and eliminations |
Total |
|---|---|---|---|---|
| Revenue from contracts with customers | 214 303 | 78 500 | - | 292 804 |
| Revenue from other group segments | 3 400 | 821 | (4 221) | - |
| Total revenue | 217 703 | 79 322 | (4 221) | 292 804 |
| Other operating income | 24 | - | - | 24 |
| Total income | 217 727 | 79 322 | (4 221) | 292 827 |
| Operating expenses 1) | (181 776) | (63 852) | (3 950) | (249 577) |
| Depreciation and amortization | (13 917) | (2 255) | (395) | (16 567) |
| Impairment | (97) | - | - | (97) |
| Operating profit | 21 937 | 13 215 | (8 567) | 26 586 |
| EBITDA 2) | 35 948 | 17 600 | (8 171) | 45 377 |
| Adjusted EBITDA 2) | 35 948 | 17 600 | (8 171) | 45 377 |
| Purchase of non-current assets during the quarter | 11 821 | 13 748 | 3 303 | 28 872 |
| Quarter ended September 30, 2023 | EMEA | Americas | Other and eliminations |
Total |
|---|---|---|---|---|
| Revenue from contracts with customers | 211 527 | 71 744 | 189 | 283 460 |
| Revenue from other group segments | 9 693 | 337 | (10 031) | - |
| Total revenue | 221 220 | 72 081 | (9 842) | 283 460 |
| Other operating income | 33 | - | - | 33 |
| Total income | 221 253 | 72 081 | (9 842) | 283 493 |
| Operating expenses 1) | (181 100) | (57 530) | 1 570 | (237 060) |
| Depreciation and amortization | (13 223) | (1 831) | (604) | (15 658) |
| Impairment | (400) | - | - | (400) |
| Operating profit | 26 531 | 12 720 | (8 877) | 30 375 |
| EBITDA 2) | 40 152 | 16 447 | (8 272) | 48 327 |
| Adjusted EBITDA 2) | 40 153 | 16 447 | (8 272) | 48 327 |
| Purchase of non-current assets during the quarter | 4 347 | 442 | (255) | 4 535 |
| Year to date ended September 30, 2024 | EMEA | Americas | Other and eliminations |
Total |
|---|---|---|---|---|
| Revenue from contracts with customers | 648 425 | 224 400 | 286 | 873 110 |
| Revenue from other group segments | 19 314 | 1 794 | (21 108) | - |
| Total revenue | 667 739 | 226 194 | (20 822) | 873 110 |
| Other operating income | 25 | - | - | 25 |
| Total income | 667 764 | 226 194 | (20 822) | 873 136 |
| Operating expenses 1) | (559 005) | (181 054) | (4 789) | (744 849) |
| Depreciation and amortization | (40 229) | (5 909) | (1 230) | (47 369) |
| Impairment | (672) | - | - | (672) |
| Operating profit | 67 858 | 39 230 | (26 841) | 80 247 |
| EBITDA 2) | 108 758 | 52 121 | (25 611) | 135 268 |
| Adjusted EBITDA 2) | 108 758 | 52 121 | (25 611) | 135 268 |
| Purchase of non-current assets during the year | 29 238 | 37 718 | 1 143 | 68 099 |
| Other and | ||||
|---|---|---|---|---|
| Year to date ended September 30, 2023 | EMEA | Americas | eliminations | Total |
| Revenue from contracts with customers | 634 973 | 209 275 | 627 | 844 876 |
| Revenue from other group segments | 16 012 | 953 | (16 963) | 1 |
| Total revenue | 650 985 | 210 228 | (16 335) | 844 877 |
| Other operating income | 35 | - | - | 35 |
| Total income | 651 019 | 210 228 | (16 335) | 844 912 |
| Operating expenses 1) | (544 120) | (167 893) | (6 153) | (718 167) |
| Depreciation and amortization | (38 488) | (5 332) | (1 832) | (45 652) |
| Impairment | (567) | - | - | (567) |
| Operating profit | 67 843 | 37 003 | (24 320) | 80 526 |
| EBITDA 2) | 106 889 | 46 447 | (22 489) | 130 847 |
| Adjusted EBITDA 2) | 106 889 | 46 447 | (22 489) | 130 847 |
| Purchase of non-current assets during the year | 19 282 | 411 | 11 | 19 704 |
1) Operating expenses include cost of materials, payroll expenses, and other operating expenses.
2) See the APM disclosure for the reconciliation of EBITDA and adjusted EBITDA. With effect from the third quarter of 2024, the definition of EBITDA has changed to include share of net profit from joint ventures. As a consequence, the comparatives have been updated accordingly.
As of September 2024, net change in fair value of financial instruments is reported in a separate line in the net financial items. Comparable figures are restated.
In tax disputes, the Group accounts for tax costs according to decisions made by local tax authorities, or according to subsequent tax rulings in the actual case, or similar cases. A dividend distribution from Elopak Systems AG to Elopak ASA, formerly Elopak AS, in 2011 and 2014 was deemed to be taxable income for Elopak ASA in a decision by Norwegian tax office in 2017. The full tax cost of NOK 69.6 million was recognized and paid in accordance with the ruling at that time. Elopak lost in the Oslo district court in 2022 and Borgarting court of appeal in March 2024. The Supreme court has accepted to rule on the case. The court is expected to hear the case in early 2025.
The reconciliation between tax (expense) / income and accounting profit / (loss) before taxes is as follows for the continuing
| operations | Quarter ended September 30 | Year to date ended September 30 | |||
|---|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 | |
| Profit before taxes | 17 196 | 26 726 | 68 537 | 69 569 | |
| Expected Tax (expense) income at statutory rate1 | (4 127) | (6 414) | (16 449) | (16 697) | |
| Prior period adjustments | - | 6 | (1 990) | 127 | |
| Tax effect of share profit/(loss) from joint ventures | 511 | 455 | 1 675 | 985 | |
| Tax effect of other permanent differences | 108 | (78) | 229 | 187 | |
| Tax effect on currency valuation 2 | 2 482 | (1 193) | 2 857 | 2 187 | |
| Witholding tax | (614) | (122) | (817) | (459) | |
| Tax (expense) income recognised in profit or loss | (1 639) | (7 348) | (14 493) | (13 671) |
1 The expected tax at weighted statutory tax rate of 24% (24% in 2023) is based on an estimate of where the Group taxes its profits and the corresponding applicable tax rates
2 The tax effect on currency valuation is derived from Elopak ASA tax filing submitted in NOK against a functional currency in Euro.
Elopak has issued senior unsecured green bonds with a total amount of NOK 2.5 billion. The settlement date is May 28 of the maturity year. The bonds have been swapped to floating Euribor.
The transaction was split into three tranches:
| (EUR 1,000) | September 30, 2024 | ||||
|---|---|---|---|---|---|
| Currency | Nominal interest rate | Year of maturity | Face value | Carrying amount | |
| Unsecured bond issues | NOK | Nibor +1.20% p.a. | 2027 | 63 751 | 63 906 |
| Unsecured bond issues | NOK | Nibor +1.50% p.a. | 2029 | 106 252 | 106 557 |
| Unsecured bond issues | NOK | 5.48% | 2031 | 42 501 | 43 155 |
The green bonds are initially recognized at cost, being the fair value of the consideration received net of incremental cost, and subsequently measured at amortized cost using the effective interest method. The cross-currency swaps are recognized as financial income or financial expense in profit or loss, in line with the accounting policy set out in the annual IFRS financial statements for the year ended December 31, 2023.
The EUR 400 million multi-currency revolving credit facility expiring in May 2025 has been repaid in full and cancelled. A new revolving credit facility has been entered into on June 12, 2024 for EUR 210 million which is available until June 2029. As of September 30, 2024 EUR 20 million is utilized.
The Board approved a dividend of NOK 1.46 per share for the financial year 2023 on May 13, 2024. The dividend payment was EUR 34.4 million based on 269 219 014 outstanding shares, of which EUR 20.2 million was paid to Ferd AS.
Ferd AS reduced their total shareholding to 44.4% in September 2024. Elopak ASA is a subsidiary of Ferd AS and is consolidated within their consolidated financial statements.
| September 30, 2024 | September 30, 2023 | December 31, 2023 | |||||||
|---|---|---|---|---|---|---|---|---|---|
| (EUR 1,000) | Assets | Liabilities | Total | Assets | Liabilities | Total | Assets | Liabilities | Total |
| Currency derivatives | 608 | 10 352 | (9 743) | 465 | 7 724 | (7 259) | 904 | 7 398 | (6 494) |
| Commodity derivatives | - | 200 | (200) | 23 | 296 | (274) | 31 | 2 408 | (2 377) |
| Interest derivatives | 2 199 | 3 743 | (1 544) | 6 540 | - | 6 540 | 3 650 | 2 105 | 1 545 |
| Total | 2 807 | 14 294 | (11 487) | 7 028 | 8 020 | (992) | 4 585 | 11 911 | (7 326) |
The full fair value of a derivative is classified as "Other non-current assets" or "Other non-current liabilities" if the remaining maturity of the derivative is more than 12 months and, as "Other current assets" or "Other current liabilities", if the maturity of the derivative is less than 12 months. The fair value estimation of derivative financial instruments has been arrived at by applying a level 2 valuation methodology which uses inputs other than unadjusted quoted prices for identical assets and liabilities, with changes in fair value are therefore recognized in the income statement. No other material financial assets or liabilities are measured at fair value through profit or loss.
Where eligible, derivatives used for hedging are designated in cash flow hedge accounting relationships.
Note 9 Off-balance sheet commitments and contingencies
Commitments for the acquisition of property, plant and equipment is EUR 25.6 million as of September 30, 2024 and EUR 1.1 million as of September 30, 2023. The increase during the period is primarily related to the construction of our new production plant in Little Rock, Arkansas.
The Group prepares and reports its consolidated financial statements in accordance with International Financial Reporting Standards as issued by the IASB and as endorsed by the EU (IFRS). In addition, the Group presents several Alternative Performance Measures (APMs).
In accordance with European Securities and Market Authority (ESMA) guidelines dated May 10, 2015, an APM is understood as a financial measure of historical or future financial performance, financial position, or cash flows, other than a financial measure defined or specified in the applicable financial reporting framework (IFRS). It should be noted that these measures do not have any standardized meaning prescribed by IFRS and therefore are not necessarily comparable to the calculation of similar measures used by other companies. The APMs are regularly reviewed by the Group's management. The APMs are reported in addition to but are not substitutes for the Group's consolidated financial statements, prepared in accordance with IFRS.
The APMs provide supplementary information to measure the Group's performance and to enhance comparability between financial periods. The APMs also provide measures commonly reported and widely used by investors, lenders, and other stakeholders as an indicator of the Group's performance. These APMs are among others, used in planning and for forecasting future periods, including assessing our ability to incur and service debt including covenant compliance. APMs are defined consistently over time and are based on the Group's consolidated financial statements (IFRS).
Organic revenue is a measure of revenue adjusted for currency effects and effects of acquisition and disposal of operations. The Group presents this APM because management considers it to provide useful supplemental information for understanding the Group's revenue development over time for comparability purposes.
| Quarter ended September 30, Change Year to date ended September 30, |
Change | |||||
|---|---|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 | ||
| Total revenue and other operating income | 292 827 | 283 493 | 3.3% | 873 136 | 844 912 | 3.3% |
| Currency effect | 779 | 862 | ||||
| Acquisition and disposal effect | - | - | ||||
| Organic revenue | 293 606 | 283 493 | 3.6% | 873 998 | 844 912 | 3.4% |
| Quarter ended September 30, | Change | Year to date ended September 30, | Change | |||
|---|---|---|---|---|---|---|
| (EUR 1,000) | 2023 | 2022 | 2023 | 2022 | ||
| Total revenue and other operating income | 283 493 | 272 425 | 4.1% | 844 912 | 756 697 | 11.7% |
| Currency effect | 2 112 | 5 377 | ||||
| Acquisition and disposal effect | - | (23 556) | (350) | |||
| Organic revenue | 285 605 | 272 425 | 4.8% | 826 733 | 756 347 | 9.3% |
EBITDA is a measure of earnings before interest, taxes, depreciation, amortization, and impairments. As of Sep 30, 2024, management has expanded their definition of EBITDA to include share of net income from joint ventures. This has previously been a part of our "adjusted EBITDA". Management considers the earnings from joint ventures. to be a part of the Group's core business and that including it gives a more comprehensive view of our earnings.
The Group presents this APM because management considers it to provide useful supplemental information for understanding the overall picture of profit generation in the Group's operating activities and for comparing its operating performance with that of other companies.
Adjusted EBITDA is a measure of EBITDA adjusted for certain items affecting comparability (the Adjustment items). The Group presents this APM because management considers it to be an important supplemental measure for understanding the underlying profit generation in the Group's operating activities and comparing its operating performance with that of other companies.
| Quarter ended September 30, | Year to date ended September 30, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 |
| Operating profit | 26 586 | 30 375 | 80 247 | 80 526 |
| Depreciation, amortization and impairment | 16 664 | 16 058 | 48 040 | 46 219 |
| Share of net income from joint ventures | 2 127 | 1 894 | 6 981 | 4 102 |
| EBITDA | 45 377 | 48 327 | 135 268 | 130 847 |
| Total adjusted items with EBITDA impact | - | - | - | - |
| Adjusted EBITDA | 45 377 | 48 327 | 135 268 | 130 847 |
EBIT is a measure of earnings before interests and taxes. The Group presents this APM because management considers it to provide useful supplemental information for understanding the overall picture of profit generation in the Group's operating activities and for comparing its operating performance with that of other companies.
Adjusted EBIT is a measure of EBIT adjusted for certain items affecting comparability (the Adjustment items). The Group presents this APM because management considers it to be an important supplemental measure for understanding the underlying profit generation in the Group's operating activities and comparing its operating performance with that of other companies.
| Quarter ended September 30, | Year to date ended September 30, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 |
| EBITDA | 45 377 | 48 327 | 135 268 | 130 847 |
| Depreciation, amortization and impairment | (16 664) | (16 058) | (48 040) | (46 219) |
| EBIT | 28 713 | 32 269 | 87 228 | 84 628 |
| Total adjusted items with EBIT impact | - | - | - | - |
| Adjusted EBIT | 28 713 | 32 269 | 87 228 | 84 628 |
Capital employed is defined as Shareholders' Equity, including non-controlling interest, plus net debt.
Return on capital employed (ROCE) is defined as adjusted EBIT for the last four quarters divided by the average capital employed, measured for the last four quarters. ROCE is an important metric for the Group to measure its capital efficiency. Since it takes into account both debt and equity, management considers this to provide a holistic view of the Group's profitability.
| Quarter ended September 30, 2024 | 2024 | 2024 | 2024 | 2023 |
|---|---|---|---|---|
| (EUR 1,000) | Q3 | Q2 | Q1 | Q4 |
| Operating profit | 26 586 | 25 816 | 27 846 | 22 252 |
| Share of net income from joint ventures | 2 127 | 2 605 | 2 248 | 2 753 |
| EBIT | 28 713 | 28 421 | 30 094 | 25 005 |
| Total adjusted items with EBIT impact | - | - | - | (100) |
| Adjusted EBIT | 28 713 | 28 421 | 30 094 | 24 905 |
| Adjusted EBIT, last 4 quarters | 112 133 | |||
| Net debt | 371 250 | 338 510 | 313 231 | 332 545 |
| Equity | 329 657 | 325 284 | 341 603 | 315 296 |
| Capital employed | 700 907 | 663 794 | 654 834 | 647 841 |
| Capital employed, average last 4 quarters | 666 844 | |||
| ROCE | 16.8 % |
| Quarter ended September 30, 2023 | 2023 | 2023 | 2023 | 2022 |
|---|---|---|---|---|
| (EUR 1,000) | Q3 | Q2 | Q1 | Q4 |
| Operating profit | 30 375 | 25 493 | 24 658 | 16 105 |
| Share of net income from joint ventures | 1 894 | 1 196 | 1 012 | 991 |
| EBIT | 32 269 | 26 689 | 25 670 | 17 096 |
| Total adjusted items with EBIT impact | - | - | - | 1 102 |
| Adjusted EBIT | 32 269 | 26 689 | 25 670 | 18 198 |
| Adjusted EBIT, last 4 quarters | 102 826 | |||
| Net debt | 347 794 | 385 561 | 367 135 | 391 473 |
| Equity | 307 542 | 283 477 | 283 456 | 267 967 |
| Capital employed | 655 336 | 669 039 | 650 591 | 659 441 |
| Capital employed, average last 4 quarters | 658 602 | |||
| ROCE | 15.6 % |
Adjusted profit attributable to Elopak shareholders represents the Group's profit attributable to Elopak shareholders adjusted for certain items affecting comparability, taking into account the Adjustment items, related estimated calculatory tax effects based on a 24% weighted statutory tax rate and excluding historical share of net income from joint ventures that have been discontinued. The Group presents this APM because management considers it to provide useful supplemental information for understanding the Group's profit attributable to Elopak shareholders and for comparability purposes with other companies.
| Quarter ended September 30, | Year to date ended September 30, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 |
| Profit attributable to Elopak shareholders | 15 169 | 19 479 | 52 540 | 53 475 |
| Discontinued operations | - | - | 131 | 1 339 |
| Items excluded from adjusted EBITDA net of tax | - | - | - | - |
| Adjusted profit attributable to Elopak shareholders | 15 169 | 19 479 | 52 672 | 54 814 |
Net debt is a measure of borrowings (including interest bearing liabilities before amortization costs and lease liabilities) less cash and cash equivalents for the period. The Group presents this APM because management considers it as a useful indicator of the Group's indebtedness, financial flexibility and capital structure because it indicates the level of borrowings after taking into account cash and cash equivalents within the Group's business that could be utilized to pay down outstanding borrowings. Net debt is also used for monitoring the Group's financial covenants compliance by management.
Leverage ratio is a measure of net debt divided by adjusted EBITDA. The Group presents this APM because management considers it as a useful indicator of the Group's ability to meet its financial obligations. Net debt/adjusted EBITDA is also used for monitoring the Group's financial covenants compliance by management.
| Quarter ended September 30, | ||
|---|---|---|
| 2024 | 2023 | |
| 233 606 | 260 000 | |
| 52 908 | 20 794 | |
| (21 325) | (28 676) | |
| 265 189 | 252 118 | |
| 106 061 | 95 676 | |
| 371 250 | 347 794 | |
1 Bank debt is excluding amortized borrowing costs of EUR 0.9 million as of September 30, 2024 and EUR 0.7 million as of September 30, 2023.
| Leverage ratio 2) | 2.1 | 2.1 |
|---|---|---|
| 2)Leverage ratio is calculated based on last twelve months adjusted EBITDA of EUR 175.3 million as of September 30, 2024 and EUR 167.5 million as of Septem | ||
| ber 30, 2023. |
Adjusted EPS represents adjusted profit attributable to Elopak shareholders divided by weighted average number of ordinary shares – basic and diluted. Elopak presents adjusted basic and diluted earnings per share because management considers it to be an important supplemental measure for understanding the Group's underlying profit for the year (period) on a per share basis and comparing its profit for the year (period) on a per share basis with that of other companies in the industry.
| Quarter ended September 30, | Year to date ended September 30, | |||
|---|---|---|---|---|
| (EUR 1,000 except number of shares) | 2024 | 2023 | 2024 | 2023 |
| Weighted-average number of ordinary shares | 269 102 166 | 269 187 818 269 048 522 269 204 842 | ||
| Profit attributable to Elopak shareholders | 15 169 | 19 479 | 52 540 | 53 475 |
| Adjusted profit attributable to Elopak shareholders | 15 169 | 19 479 | 52 672 | 54 814 |
| Basic and diluted earnings per share attributable to Elopak | 0.07 | 0.20 | 0.20 | |
| shareholders (in EUR) | 0.06 | |||
| Adjusted basic and diluted earnings per share (in EUR) | 0.06 | 0.07 | 0.20 | 0.20 |
| Quarter ended September 30, | Year to date ended September 30, | |||
|---|---|---|---|---|
| (EUR 1,000) | 2024 | 2023 | 2024 | 2023 |
| Lala Elopak S.A. de C.V. | 1 652 | 1 235 | 5 354 | 2 784 |
| Impresora Del Yaque | 478 | 661 | 1 628 | 1 329 |
| Elopak Nampak Africa Ltd | (3) | (1) | (1) | (10) |
| Total share of profit joint ventures | 2 127 | 1 894 | 6 981 | 4 102 |
Christian Gjerde Treasury and Investor Relations +47 980 60 909
February 11, 2025 Quarterly Report – Q4 May 7, 2025 Quarterly Report – Q1 August 14, 2025 Half-yearly Report October 28, 2025 Quarterly Report – Q3
Chief Financial Officer +47 977 56 578
Elopak reserves the right to revise the dates
The interim report contains certain forward-looking statements. Forward-looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims", "believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", "should" and similar expressions. Any statement, estimate or projections included in the Information (or upon which any of the conclusions contained herein are based) with respect to anticipated future performance (including, without limitation, any statement, estimate or projection with respect to the condition (financial or otherwise), prospects, business strategy, plans or objectives of the Group and/or any of its affiliates) reflect, at the time made, the Company's beliefs, intentions and current targets/ aims and may prove not to be correct. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties, contingencies and other important factors which are difficult or impossible to predict and are beyond its control. No representation or warranty is given as to the completeness or accuracy of any forward-looking statement contained in the Information or the accuracy of any of the underlying assumptions.
As worldwide makers of cartonbased packaging, we are committed to remaining our customers' partner and the consumers' favorite, through relentlessly developing new solutions for an expanding range of content.
Applying market-leading technology, skills and natural material sourcing, we always aim to provide the highest quality products that leave the world unharmed.
For more information please visit www.elopak.com
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.